World EPA Congress
5 March 20257 March 2025
Amsterdam, NetherlandsRAI Congress Centre
This Congress covers market access, pricing, reimbursement, rare diseases, health technology assessments, health economics and outcomes research in healthcare.
The World Evidence Pricing and Access (EPA) Congress allows attendees to connect directly with key decision makers across 2 days of built in one to one networking.
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze